Global mRNA Cancer Vaccines And Therapeutics Market Analysis 2024 – Estimated Market Size And Key Drivers

The mRNA Cancer Vaccines And Therapeutics Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The mRNA Cancer Vaccines And Therapeutics Market:
https://www.thebusinessresearchcompany.com/report/mrna-cancer-vaccines-and-therapeutics-global-market-report

According to The Business Research Company’s mRNA Cancer Vaccines And Therapeutics Global Market Report 2024, The mRNA cancer vaccines and therapeutics market size is expected to see rapid growth in the next few years. It will grow to $113.41 billion in 2028 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period can be attributed to promising clinical trial results, growing awareness and acceptance of mRNA technology, unmet medical needs in cancer treatment, potential for improved patient outcomes and potential for off-the-shelf availability. Major trends in the forecast period include expansion into new therapeutic areas, personalized medicine approach, advancements in mRNA delivery systems, multivalent mRNA Vaccines and artificial intelligence and machine learning in mRNA design.

The rise in the prevalence of cancer is expected to propel the growth of the mRNA cancer vaccine and therapeutic market going forward. Cancer is a broad term for a group of diseases characterized by the uncontrolled growth and spread of abnormal cells, that invade and destroy normal body tissue. The rise in the prevalence of cancer is due to sedentary lifestyles, unhealthy eating habits, and exposure to environmental toxins. mRNA cancer vaccines and therapeutics are required for cancer because they offer personalized, targeted treatments that can enhance the immune system’s ability to recognize and attack cancer cells, improving treatment efficacy and patient outcomes. For instance, in January 2023, according to the data published by the American Cancer Society, a US-based non-profit organization working to eliminate cancer, the estimated number of new cancer cases in the United States, was around 1,918,030 in 2022, which increased to 1,958,310 in 2023. Breast cancer is the leading chronic condition in the United States, increasing from 287,850 cases in 2022 to 297,790 cases in 2023, respectively. Therefore, the rise in the prevalence of cancer is driving the growth of the mRNA cancer vaccine and therapeutics market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=17204&type=smp

The mRNA cancer vaccines and therapeutics market covered in this report is segmented –

1) By Type : Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas
2) By Application: Infectious Disease, Cancer, Other Applications
3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users

Major players operating in the mRNA cancer vaccine and therapeutics market are focused on the development of innovative treatments such as mRNA cancer vaccines to enhance efficacy, improve patient outcomes, and address the growing demand for effective cancer therapies. mRNA cancer vaccines are a type of immunotherapy that use messenger RNA to instruct cells to produce specific antigens, thereby stimulating the immune system to recognize and attack cancer cells. For instance, in May 2024, WestGene Biopharma, a China-based, biotechnology company received FDA approval for an investigational new drug application of its mRNA therapeutic cancer vaccine, WGc-043. The FDA approval of WGc-043 marks a breakthrough in treating advanced EB virus-related cancers, which are strongly linked to over ten malignancies, including nasopharyngeal carcinoma, NK T-cell lymphoma, and gastric, lung, liver, esophageal, breast, and cervical cancers, as well as autoimmune diseases such as multiple sclerosis and lupus.

The mrna cancer vaccines and therapeutics market report table of contents includes:

1. Executive Summary
2. mRNA Cancer Vaccines And Therapeutics Market Characteristics
3. mRNA Cancer Vaccines And Therapeutics Market Trends And Strategies
4. mRNA Cancer Vaccines And Therapeutics Market – Macro Economic Scenario
5. Global mRNA Cancer Vaccines And Therapeutics Market Size and Growth
.
.
.
32. Global mRNA Cancer Vaccines And Therapeutics Market Competitive Benchmarking
33. Global mRNA Cancer Vaccines And Therapeutics Market Competitive Dashboard
34. Key Mergers And Acquisitions In The mRNA Cancer Vaccines And Therapeutics Market
35. mRNA Cancer Vaccines And Therapeutics Market Future Outlook and Potential Analysis
36. Appendix